• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Invacare unloads rehab devices for $23M

Invacare unloads rehab devices for $23M

September 2, 2014 By Arezu Sarvestani

Invacare unloads rehab devices for $23M

Invacare (NYSE:IVC) is hoping to narrow its focus and reduce its debt after divesting its Altimate Medical subsidiary for $23 million in cash.

Invacare sold the business to Rockwood Equity Partners, saying that "Altimate is a strong business, but it is outside of Invacare’s core North America/Home Medical Equipment product portfolio."

Altimate, which manufactures stationary standing assistance devices for use in rehabilitation settings, recorded about $8.9 million in revenue and $2.3 million in profits (before taxes and adjustments) in the 1st half of 2014.

Invacare estimates that its net proceeds from the deal amount to $21.7 million, which the company hopes to use to reduce some of the outstanding debt under its revolving credit facility.

Invacare has had a rough few quarters, marked by layoffs and other cost-reduction efforts. The Ohio-based company announced last month that it would fire about 150 employees and 40 temps from its North American home medical equipment and Asia/Pacific institutional products divisions, adding to the approximately 70 layoffs tied to the closing of the company’s London, Canada, manufacturing facility earlier this year.

IVC shares dropped 2.5% today to trade at $14.96 as of about 2:35 p.m. EST. The stock has lost 35.6% since the start of the year.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Altimate Medical, Invacare, Rehabilitation Equipment, Rockwood Equity Partners

More recent news

  • DePuy Synthes launches next-generation automated fracture fixation system
  • FDA clears at-home dental dressing for non-surgical periodontal procedures
  • CVRx taps new CFO from Nyxoah
  • BD brings on new chief information and digital officer from Lenovo
  • Cooper Companies continues to see activist pressure to sell divisions, replace CEO

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy